Drug intelligence / Profile preview

phosphorylated cyclocarya paliurus polysaccharide

Development stage
Preclinical
Administration
Oral
01

Overview

Phosphorylated cyclocarya paliurus polysaccharide (P-CPP) is a structurally modified natural polysaccharide derived from the leaves of *Cyclocarya paliurus*, a plant native to China commonly known as the sweet tea tree. The phosphorylation modification is employed to enhance the biological activity and solubility of the native polysaccharides. In preclinical studies, particularly in murine models of dextran sulfate sodium (DSS)-induced colitis, P-CPPs have demonstrated potent anti-inflammatory and gut-regulatory properties. The mechanism of action involves the suppression of pro-inflammatory signaling pathways, specifically the NF-κB pathway and the NLRP3 inflammasome, which leads to a reduction in cytokines such as TNF-α and IL-6. Furthermore, P-CPPs strengthen the intestinal barrier by upregulating tight junction proteins like occludin and claudin-1, as well as the mucus barrier protein MUC-2. The compound also modulates the gut microbiota, increasing microbial diversity and the production of short-chain fatty acids (SCFAs), which contributes to the maintenance of intestinal homeostasis.

Other names
phosphorylated Cyclocarya paliurus polysaccharides
02

Targets

IL-6 (Interleukin 6)CLDN1 (Tight junction protein claudin-1)OCLN (Occludin)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on phosphorylated cyclocarya paliurus polysaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phosphorylated cyclocarya paliurus polysaccharide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call